How Light Therapy Industry Growing Tremendously?

Light Therapy Market Overview:

Registering a CAGR of 5.1%, the global Light Therapy Market is expected to reach USD 1,112.16 Million in by 2025.
 The increasing patient preference for non-invasive procedures is driving the growth of this market. Various medical facilities are now preferring to use non-invasive light therapies or phototherapies. This can be attributed to the advantages of non-invasive light therapy, such as reduced pain and better patient outcomes.
Numerous established players dominate the market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in April 2019, Philips launched VitalMinds a key technology in the personalized light therapy system, that improves sleep quality in critical care patients.

Access Full Report Details and TOC Exclusively @ https://www.marketresearchfuture.com/reports/light-therapy-market-8366

Light Therapy Market-Key Players:
·         Northern Light Technology
·         Chal-Tec GmbH
·         Beurer
·         BioPhotas
·         Lucimed SA
·         Verilux
·         Koninklijke Philips
·         Nature Bright
·         Zepter International
·         Lumie
.
Light Therapy  Market-Segmentation:
·         The global light therapy market has been segmented into product, application, light type, and end user.
·         By product, the market has been segmented into light box, floor and desk lamps, light visor, handheld devices for skin treatment (HDST), dawn simulator, light therapy bulbs, and others.
·         By application, the market has been segmented into psoriasis, vitiligo, eczema, acne vulgaris, seasonal affective disorder (SAD), and others. The psoriasis segment is estimated to hold significant market share in the market due to the increasing prevalence of psoriasis and demand for novel therapeutics. 
·         On the basis of light type, the global light therapy market has been segmented into blue light, red light, white light, and others. 
·         The global light therapy market, by end user, has been segmented into home care settings, dermatology clinics, and others.

Light Therapy  Market-Regional Analysis:
On a regional basis, the Americas is anticipated to dominate the global light therapy market owing to the rising demand for non-invasive procedures and rising prevalence of dermatological disorders in the region. For instance, about 1.9 percent of African Americans have psoriasis. Moreover, extensive research & development activities conducted by major key players operating in the market will boost market growth. For instance, in January 2018, BioPhotas launched Cellulma home, a model in the Cellulma series of light therapy products for the treatment of joint pain and arthritis. Europe is expected to hold the second-largest position in the global light therapy market owing to the rising public awareness about the benefits of light therapy devices.
Moreover, favorable reimbursement policies and insurances for light therapy or luminotherapy treatment are driving the market growth in this region. Asia-Pacific is anticipated to be fastest-growing region is due to the growing prevalence of psychological conditions such as depression and anxiety, rising interest of major key players in emerging markets, good quality healthcare infrastructure in this region. The Middle East & Africa has the least share of the global light therapy market. This is attributable to limited healthcare infrastructure and lack of awareness about light therapy devices in this region.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more